Muscle selection patterns for injection of onabotulinumtoxinA in adult patients with post-stroke lower-limb spasticity influence outcome: Results from a double-blind, placebo-controlled phase 3 clinical trial

被引:0
|
作者
Wein, T. H.
Esquenazi, A.
Ward, A. B.
Geis, C.
Liu, C.
Dimitrova, R.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
959
引用
收藏
页码:S306 / S306
页数:1
相关论文
共 50 条
  • [21] Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE)
    Masakado, Yoshihisa
    Abo, Masahiro
    Kondo, Kunitsugu
    Saeki, Satoru
    Saitoh, Eiichi
    Dekundy, Andrzej
    Hanschmann, Angelika
    Kaji, Ryuji
    JOURNAL OF NEUROLOGY, 2020, 267 (07) : 2029 - 2041
  • [22] Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE)
    Yoshihisa Masakado
    Masahiro Abo
    Kunitsugu Kondo
    Satoru Saeki
    Eiichi Saitoh
    Andrzej Dekundy
    Angelika Hanschmann
    Ryuji Kaji
    Journal of Neurology, 2020, 267 : 2029 - 2041
  • [23] A randomized, double-blind, placebo-controlled trial of DaxibotulinumtoxinA for Injection for the treatment of upper limb spasticity in adults after stroke or traumatic brain injury
    Patel, Atul T.
    Munin, Michael C.
    Ayyoub, Ziyad
    Francisco, Gerard E.
    Kazerooni, Rashid
    Gross, Todd M.
    PM&R, 2025, 17 (02) : 126 - 136
  • [24] A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design
    Guekht, Alla
    Skoog, Ingmar
    Korczyn, Amos D.
    Zakharov, Vladimir
    Eeg, Martin
    Vigonius, Ulf
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2013, 3 (01): : 459 - 467
  • [26] OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results from the Double-Blind, Randomized, Placebo-Controlled Phase of the PREEMPT Clinical Program
    Dodick, David W.
    Aurora, Sheena K.
    Turkel, Catherine C.
    DeGryse, Ronald E.
    Silberstein, Stephen D.
    Lipton, Richard B.
    Diener, Hans-Christopher
    Brin, Mitchell F.
    NEUROLOGY, 2010, 74 (09) : A281 - A281
  • [27] OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phase of the PREEMPT clinical program
    Dodick, D. W.
    Aurora, S. K.
    Turkel, C. C.
    DeGryse, R. E.
    Silberstein, S. D.
    Lipton, R. B.
    Diener, H. C.
    Brin, M. F.
    TOXICON, 2013, 68 : 110 - 110
  • [28] Does botulinum toxin injection site determine outcome in post-stroke plantarflexion spasticity? Comparison study of two injection sites in the gastrocnemius muscle: a randomized double-blind controlled trial
    Im, Sun
    Park, Joo Hyun
    Son, Seong Kon
    Shin, Jae-Eun
    Cho, Sae Hoon
    Park, Geun-Young
    CLINICAL REHABILITATION, 2014, 28 (06) : 604 - 613
  • [29] Investigation into the effect of botulinum toxin type A (BoNTA) on walking speed in post-stroke patients: A double-blind, placebo-controlled trial
    Napier-Flood, Fiona
    Olver, John
    Rogers, John D.
    Deane, Jane
    NEUROLOGY, 2007, 68 (12) : A156 - A157
  • [30] Natalizumab Versus Placebo in Patients with Acute Ischemic Stroke (AIS): Results from ACTION, a Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase 2 Clinical Trial
    Elkins, Jacob
    Elkind, Mitchell
    Veltkamp, Roland
    Montaner, Joan
    Johnston, S.
    Singhal, Aneesh
    Becker, Kyra
    Lansberg, Maarten
    Chang, Ih
    Tang, Weihua
    Gheuens, Sarah
    Mehta, Lahar
    NEUROLOGY, 2016, 86